Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter C Meijers

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
JACC. Cardiooncology|August 24, 2023
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart FailurePieter F van den Berg, Joseph Pierre Aboumsallem, Elles M Screever, et al.
British Journal of Pharmacology|November 10, 2022
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatmentTamás G Gergely, Dániel Kucsera, Viktória E Tóth, et al.
European Journal of Heart Failure|June 22, 2019
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrationsChristian Mueller, Kenneth McDonald, Rudolf A de Boer, et al.
European Heart Journal|July 9, 2026
Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registryYusuf Ziya Sener, Parsa Jahangiri, Kevin Veen, et al.
Circulation. Heart Failure|February 1, 2018
Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure PatientsNiels Grote Beverborg, IJsbrand T Klip, Wouter C Meijers, et al.
Circulation|February 21, 2018
Heart Failure Stimulates Tumor Growth by Circulating FactorsWouter C Meijers, Manuel Maglione, Stephan J L Bakker, et al.
Cardio-Oncology (London, England)|August 5, 2024
Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHFP F van den Berg, L I Yousif, G Markousis-Mavrogenis, et al.
European Heart Journal|March 5, 2024
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidenceNabil V Sayour, Ágnes M Paál, Pietro Ameri, et al.
European Journal of Preventive Cardiology|September 27, 2025
Framingham risk score associates with incident cancer and heart failurePieter F van den Berg, Laura I Yousif, Yvonne Koop, et al.
European Journal of Heart Failure|October 12, 2022
Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkersCanxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
JACC. Cardiooncology|August 24, 2023
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart FailurePieter F van den Berg, Joseph Pierre Aboumsallem, Elles M Screever, et al.
British Journal of Pharmacology|November 10, 2022
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatmentTamás G Gergely, Dániel Kucsera, Viktória E Tóth, et al.
European Journal of Heart Failure|June 22, 2019
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrationsChristian Mueller, Kenneth McDonald, Rudolf A de Boer, et al.
European Heart Journal|July 9, 2026
Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registryYusuf Ziya Sener, Parsa Jahangiri, Kevin Veen, et al.
Circulation. Heart Failure|February 1, 2018
Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure PatientsNiels Grote Beverborg, IJsbrand T Klip, Wouter C Meijers, et al.
Circulation|February 21, 2018
Heart Failure Stimulates Tumor Growth by Circulating FactorsWouter C Meijers, Manuel Maglione, Stephan J L Bakker, et al.
Cardio-Oncology (London, England)|August 5, 2024
Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHFP F van den Berg, L I Yousif, G Markousis-Mavrogenis, et al.
European Heart Journal|March 5, 2024
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidenceNabil V Sayour, Ágnes M Paál, Pietro Ameri, et al.
European Journal of Preventive Cardiology|September 27, 2025
Framingham risk score associates with incident cancer and heart failurePieter F van den Berg, Laura I Yousif, Yvonne Koop, et al.
European Journal of Heart Failure|October 12, 2022
Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkersCanxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, et al.
Pageof 10